Koon v. Walden is still making an impact on opioid prescribing in America, but insurance companies and legislatures are putting higher hurdles in place to limit damages and restrict the patient’s ability to have their day in court. In this update, Johnny Simon and Tim Cronin discuss the impact of the case on prescribing behavior, nationwide medical training, and potential opioid litigation.